We thus evaluated the expression of PKM2 (a key Warburg-metabolism protein) and O-GlcNAc (a nutrient-status integrator) in a retrospective cohort of luminal HR+/HER2− BC. The gene discussed is ERBB2; the disease is breast cancer.